Collecting the data for, and developing a predictive model to identify lapse and relapse to support people who want to change their relationship with alcohol

收集数据并开发预测模型来识别戒酒和复发，以支持那些想要改变与酒精关系的人

• 批准号: 10045638
• 金额: $ 6.14万
• 依托单位: MIND HEALTH AI LIMITED
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10045638
• 关键词: Collecting; data; developing; predictive; model

Mind Health AI is a digital therapeutics start up, making cutting-edge science and technology accessible to both consumers and clinicians. We support individuals who want to change harmful behaviours and self--manage chronic health conditions, via predictive models generated by machine learning.We have a diverse, UK-based founding team with expertise in clinical, commercial and technical domains. Our combined professional experience provides a wealth of relationships, with realistic routes to market and institutional investment, and real potential for scaling.Our first product is alma, a mobile application which helps users beat cravings and quit drinking. Alcohol consumption is linked as a causal factor to more than 60 diseases, but although a range of interventions has been available for decades, the parlous state of care for alcohol dependency means that 90% of people who go through rehab relapse within five years. On this specific project, we seek to recruit users, building a dataset large enough to inform algorithms that can predict negative health outcomes, including cravings, lapse, full relapse and service disengagement.We are working with academics at the global forefront of their fields in behavioural science, predictive models and digital therapeutics. The value proposition of our product has been validated by stakeholder groups, including people seeking to quit drinking, as well as clinicians and professionals in related industries such as insurance and pharmaceuticals.

Mind Health AI是一种数字治疗剂，使消费者和临床医生都可以使用尖端的科学和技术。我们支持想要通过机器学习产生的预测模型来改变有害行为和自我管理的慢性健康状况的个人。我们拥有一支具有临床，商业和技术领域专业知识的英国成立团队。我们合并的专业经验提供了丰富的关系，以及现实的市场和机构投资的途径，以及实际扩展的潜力。我们的第一产品是Alma，它是一种移动应用程序，可帮助用户击败渴望和戒酒。饮酒量是与60多种疾病的因果因素有关的，但是尽管几十年来已经进行了一系列干预措施，但酒精依赖的偏执状态意味着在五年内经过康复复发的人中有90％。在这个特定项目中，我们寻求招募用户，构建一个足够大的数据集，以告知算法，这些算法可以预测负面的健康状况，包括渴望，失败，完全复发和服务脱离接触。我们正在与他们在其全球领域的学者合作，行为科学，预测模型和数字治疗学。利益相关者群体（包括寻求退出饮酒的人）以及保险和药品等相关行业的临床医生和专业人士，包括寻求戒酒的人，包括我们产品的价值主张。